Key facts
- SiPhox Health’s last known valuation is $185.0M (Jan 2026).
- It has raised $67.2M across 2 recorded rounds; the latest was Early Stage VC (Series A) ($17.0M) in Jul 2023.
- Notable investors include Y Combinator, Alumni Ventures, Khosla Ventures, Metaplanet Holdings, Balaji Srinivasan — 27 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for SiPhox Health
Funding rounds
2 roundsAbout SiPhox Health
Operator of a biosensing platform intended to provide a handheld device that accepts disposable cartridges. The company's platform merges biochemistry and photonic chip technology and combines integrated photonics, electronics, and microfluidics to provide a sensitive readout of immunoassays and ribonucleic acid or deoxyribonucleic acid, enabling users to undertake tests at point-of-need and at-home diagnostics.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Burlington, MA, United States
- Founded
- 2020
- Employees
- 49
- Website
- siphoxhealth.com/
- Ownership
- Privately Held (backing)
SiPhox Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SiPhox Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SiPhox Health in its N-PORT filings yet. We sweep new filings monthly.